Literature DB >> 6660903

Variations in skin photosensitization during repeated oral 8-methoxypsoralen medication.

C T Jansén, G Wilén, R Paul.   

Abstract

Nine adult volunteer dermatological patients were subjected to five repeated oral exposures of 0.6 mg/kg of 8-methoxypsoralen at near-fasting conditions. In the individual volunteer, the plasma 2-h drug level varied by a factor of 1.3 to 7.1, mean 3.5. The simultaneously measured skin minimal UVA sensitivity varied in the individual subjects by a factor of 1.3 to 3.8, mean 2.2. When all serum level and skin photosensitivity data of the study were tabulated, a negative correlation factor of 0.5758 was obtained, which is statistically highly significant (P less than 0.001). It is concluded that both serum drug levels and degree of skin photosensitivity may fluctuate considerably in a single subject during repeated exposures to a standard oral 8-methoxsalen dose. Attempts should be made to minimize such undesirable variation by improvements of drug formulations and better consideration of the influence of dietary factors on drug absorption.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660903     DOI: 10.1007/bf00417204

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.

Authors:  J A Parrish; T B Fitzpatrick; L Tanenbaum; M A Pathak
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

2.  Dietary influences on 8-MOP plasma levels in PUVA patients with psoriasis.

Authors:  R Roelandts; M Van Boven; T Deheyn; G Vander Stichele; H Degreef; P Daenens
Journal:  Br J Dermatol       Date:  1981-11       Impact factor: 9.302

3.  8-MOP plasma levels in PUVA problem cases with psoriasis.

Authors:  G Wagner; C Hofmann; U Busch; J Schmid; G Plewig
Journal:  Br J Dermatol       Date:  1979-09       Impact factor: 9.302

4.  Intraindividual variations of 8-methoxypsoralen plasma levels.

Authors:  M Schäfer-Korting; H C Korting
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis.

Authors:  G Swanbeck; H Ehrsson; M Ehrnebo; I Wallin; L Jonsson
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

6.  Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers.

Authors:  B Ljunggren; D M Carter; J Albert; T Reid
Journal:  J Invest Dermatol       Date:  1980-01       Impact factor: 8.551

7.  Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.

Authors:  B Ljunggren; M Bjellerup; D M Carter
Journal:  J Invest Dermatol       Date:  1981-02       Impact factor: 8.551

8.  Serum levels of 8-methoxypsoralen 2 hours after oral administration.

Authors:  I Steiner; T Prey; F Gschnait; J Washüttl; F Greiter
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

9.  Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tablets.

Authors:  P Thune
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

10.  Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation.

Authors:  P Thune; G Volden
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

  10 in total
  1 in total

Review 1.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.